ProPhase Labs to Present at the Investor Summit Virtual on March 11
Rhea-AI Summary
ProPhase Labs (NASDAQ: PRPH), a next-generation biotech, genomics, and consumer products company, has announced its participation in the upcoming Q1 Investor Summit Virtual on March 11, 2025. CEO Ted Karkus will deliver a presentation at 1:30 P.M. ET.
The Investor Summit is an exclusive event focused on small and microcap stocks, specifically targeting undervalued MicroCap companies with catalysts. The event provides investors an opportunity to interact with management teams, learn from industry experts, and network with peers.
Interested investors can register for free at the Investor Summit Group website to access the presentation, which will be available at the provided webcast link.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, PRPH gained 2.09%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today announced that Ted Karkus, CEO, will be presenting at this year’s Investor Summit Virtual on March 11th.
Event: Q1 Investor Summit
Presentation Time: 1:30 P.M. ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52134
Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.
This quarter's event is focused on MicroCap companies who are undervalued and have a catalyst.
Registration for Investors
To request free registration, please go to https://investorsummitgroup.com and click the “Registration” button.
About ProPhase Labs
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value.
Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
investorrelations@prophaselabs.com
Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman
212-812-7680
Jboidman@renmarkfinancial.com
FAQ
When is ProPhase Labs (PRPH) presenting at the Q1 Investor Summit Virtual 2025?
How can investors attend ProPhase Labs' (PRPH) Investor Summit presentation?
What is the focus of the Q1 Investor Summit where PRPH is presenting?
Who will represent ProPhase Labs (PRPH) at the Q1 2025 Investor Summit?
